Lessons learned from the COX-2 advisory hearings.
Somberg
J
J
D026683:Advisory Committees / Q000941:ethics; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000592:standards; D006801:Humans; D007880:Legislation, Drug / Q000592:standards; D011358:Product Surveillance, Postmarketing / Q000379:methods / Q000592:standards; D014481:United States; D014486:United States Food and Drug Administration
D016861:Cyclooxygenase Inhibitors